Stocks and Investing Stocks and Investing
Wed, April 6, 2022
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022

Nicole Germino Maintained (ASMB) at Strong Buy with Decreased Target to $144 on, Apr 1st, 2022


Published on 2024-10-27 20:16:34 - WOPRAI, Nicole Germino
  Print publication without navigation


Nicole Germino of Truist Securities, Maintained "Assembly Biosciences, Inc." (ASMB) at Strong Buy with Decreased Target from $180 to $144 on, Apr 1st, 2022.

Nicole, nor any peers, have made any analyst calls on ASMB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30